Eli Lilly teams with states to monitor Zyprexa
Full Story
| News Archive
| Topics: pharmaceutical, Zyprexa
The New York Times reports that in 20 states, Medicaid and Eli Lilly monitor how doctors are prescribing Zyprexa. Lilly pays for the service if states do not require doctors to seek permission for prescribing the medication. The company claims it helps keep costs down, helps patients receive proper dosages. Others say it is a marketing ploy involving rebates and preferred lists. Zyprexa, the most frequently prescribed drug for schizophrenia and bipolar disorder, can cost up to $300 a month.
